When you launch a product, is only normal for marketers to try and keep it as general as possible. However, when it comes to clinical or medical products, you better be on the lookout for people who may be monitoring you. That is just the case on what happened to Bayer Corp’s Yaz birth control pill where it claimed to be the total solution for women with post menstrual disorder.

The problem is that they generalized too much, not taking into account the various cases of PMS. Further, Yaz has not shown any proof that it is indeed catered to women with PMS of all types.

With that said, Bayer has been tagged for showing misleading commercial ads. Perhaps a better insight or proof on how Yaz can really help PMS-stricken women can save the day for Bayer Corp.

(Source) Top News

Brian Yalung is an Editor at Talent Zoo mainly contributing to latest news and issues on advertising and marketing. He is the editor for Beyond Madison Avenue and Beneath the Brand Blogs of Talent Zoo.

Article Tags: ads | bayer corp | pms | women | yaz
Filed under: Advertising, Branding, Industry News, promotion